You searched for "regeneration"
Bosch-Boonstro-Schaaff optic atrophy syndrome (BBSOAS) NR2F1 mutation
An experienced ophthalmologist can make an anatomical diagnosis of childhood visual impairment based upon the surgical sieve, i.e., congenital and acquired. But an ophthalmologist cannot work in isolation to make an aetiological diagnosis – one would require the help of...Acute dacryoadenitis secondary to COVID-19
Acute dacryoadenitis is defined as the rapid onset of discomfort and swelling of the lacrimal gland, classically giving rise to an S-shaped ptosis [1]. Dacryoadenitis is the most common cause of a painful mass in the lacrimal gland in young...Like a moth to AC flare: CMV-associated hypertensive anterior uveitis
Hypertensive anterior uveitis can present a diagnostic challenge to clinicians working in emergency eye departments. While prompt initial control of intraocular pressure (IOP) and inflammation is essential, elucidating the underlying aetiology is critical for long-term visual outcomes. When there is...Traffic Lights
For this issue’s instalment of The Culture Section, I was privileged to speak to Moorfield’s first prize competition winner Charlotte Zheng. Earlier this year in January, Charlotte wrote a patient reflection poem for the prize competition titled ‘Patient as Teacher...Lord Trees and Baroness Sugg call to end Neglected Tropical Diseases with charity coalition at Westminster event
UK Coalition against Neglected Tropical Diseases works alongside co-host parliamentary reception in the House of Lords.
Effects of ML4 on the eye
Mucolipidosis type IV (ML4) is an autosomal recessive lysosomal storage disease and is caused by variants of the MC0LN1 gene. It often presents in young individuals with eye and ocular adnexa issues. The authors present a case report and literature...Researchers pursue personalised pathways for glaucoma care
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
